Regulatory considerations for developing remote measurement technologies for Alzheimer’s disease research

The Remote Assessment of Disease and Relapse – Alzheimer’s Disease (RADAR-AD) consortium evaluated remote measurement technologies (RMTs) for assessing functional status in AD. The consortium engaged with the European Medicines Agency (EMA) to obtain feedback on identification of meaningful function...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gül Erdemli, Margarita Grammatikopoulou, Bertil Wagner, Srinivasan Vairavan, Jelena Curcic, Dag Aarsland, Gayle Wittenberg, Spiros Nikolopoulos, Marijn Muurling, Holger Froehlich, Casper de Boer, Niraj M. Shanbhag, Vera J. M. Nies, Neva Coello, Dianne Gove, Ana Diaz, Suzanne Foy, Wim Dartee, Anna-Katharine Brem
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-09-01
coleção:	npj Digital Medicine
Acesso em linha:	https://doi.org/10.1038/s41746-024-01211-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!